Entity Common Stock, Shares Outstanding of Inhibitor Therapeutics, Inc. from 14 Nov 2013 to 13 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Inhibitor Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 14 Nov 2013 to 13 Nov 2025.
  • Inhibitor Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 13 Nov 2025 was 172,573,545, a 0.14% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Inhibitor Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 172,573,545 +250,000 +0.14% 13 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 172,573,545 +250,000 +0.14% 13 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 172,323,545 +300,000 +0.17% 28 Mar 2025 10-K 28 Mar 2025 2024 FY
Q3 2024 172,323,545 +300,000 +0.17% 12 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 172,323,545 +325,000 +0.19% 06 Aug 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 172,023,545 +230,411 +0.13% 29 Mar 2024 10-K 29 Mar 2024 2023 FY
Q3 2023 172,023,545 -204,834,778 -54% 13 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 171,998,545 -204,859,778 -54% 11 Aug 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 171,793,134 -205,065,189 -54% 31 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 376,858,323 0 0% 14 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 376,858,323 0 0% 12 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 376,858,323 +981,962 +0.26% 30 Mar 2022 10-K 30 Mar 2022 2021 FY
Q3 2021 376,858,323 12 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 376,858,323 +3,222,450 +0.86% 13 Aug 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 375,876,361 +5,430,176 +1.5% 26 Mar 2021 10-K 26 Mar 2021 2020 FY
Q4 2020 373,635,873 16 Nov 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 373,635,873 +3,189,688 +0.86% 12 Aug 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 370,446,185 0 0% 30 Mar 2020 10-K 30 Mar 2020 2019 FY
Q3 2019 370,446,185 +487,121 +0.13% 06 Nov 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 370,446,185 +487,121 +0.13% 12 Aug 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 370,446,185 +771,919 +0.21% 07 Mar 2019 10-K 07 Mar 2019 2018 FY
Q3 2018 369,959,064 +359,798 +0.1% 13 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 369,959,064 +359,798 +0.1% 23 Jul 2018 10-Q 23 Jul 2018 2018 Q2
Q1 2018 369,674,266 +75,000 +0.02% 01 May 2018 10-Q 01 May 2018 2018 Q1
Q3 2017 369,599,266 +69,160,996 +23% 30 Oct 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 369,599,266 +69,245,996 +23% 28 Jul 2017 10-Q 31 Jul 2017 2017 Q2
Q1 2017 369,599,266 +101,205,996 +38% 08 May 2017 10-Q 08 May 2017 2016 Q1
Q3 2016 300,438,270 +55,085,000 +22% 31 Oct 2016 10-Q 31 Oct 2016 2016 Q3
Q2 2016 300,353,270 +55,000,000 +22% 12 Aug 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 268,393,270 +56,973,333 +27% 12 May 2016 10-Q 13 May 2016 2016 Q1
Q4 2015 245,353,270 +33,933,333 +16% 01 Feb 2016 10-K 01 Feb 2016 2015 FY
Q3 2015 245,353,270 +33,933,333 +16% 04 Nov 2015 10-Q 04 Nov 2015 2015 Q3
Q2 2015 245,353,270 +203,934,072 +492% 14 Aug 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 211,419,937 +192,530,966 +1019% 13 May 2015 10-Q 13 May 2015 2015 Q1
Q4 2014 211,419,937 13 Feb 2015 10-K 13 Feb 2015 2014 FY
Q3 2014 211,419,937 +192,530,966 +1019% 10 Oct 2014 10-Q 10 Oct 2014 2014 Q3
Q2 2014 41,419,198 13 Aug 2014 10-Q 13 Aug 2014 2014 Q2
Q1 2014 18,888,971 11 Apr 2014 10-K 15 Apr 2014 2013 FY
Q3 2013 18,888,971 14 Nov 2013 10-Q 14 Nov 2013 2013 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.